These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
769 related items for PubMed ID: 16009758
21. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)]. Nakamura M, Ando Y. Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495 [Abstract] [Full Text] [Related]
22. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C. Kawaji T, Ando Y, Nakamura M, Yamashita T, Wakita M, Ando E, Hirata A, Tanihara H. Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929 [Abstract] [Full Text] [Related]
23. [Diagnosis of familial amyloid polyneuropathy type I in Argentina]. Pérez G, Romero MC, Trigo P, Lendoire J, Imventarza O, Nesse A. Medicina (B Aires); 2008 Dec; 68(4):273-81. PubMed ID: 18786882 [Abstract] [Full Text] [Related]
24. Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy. Sakaki Y, Yoshioka K, Tanahashi H, Furuya H, Sasaki H. Mol Biol Med; 1989 Apr; 6(2):161-8. PubMed ID: 2693890 [Abstract] [Full Text] [Related]
26. Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report. Muller KR, Padbury R, Jeffrey GP, Poplawski NK, Thompson P, Tonkin A, Harley HA. Liver Transpl; 2010 Apr; 16(4):470-3. PubMed ID: 20373457 [Abstract] [Full Text] [Related]
27. Recurrent syncope as persistently isolated feature of transthyretin amyloidotic polyneuropathy. Vita G, Mazzeo A, Di Leo R, Ferlini A. Neuromuscul Disord; 2005 Mar; 15(3):259-61. PubMed ID: 15725588 [Abstract] [Full Text] [Related]
28. Selective silencing of a mutant transthyretin allele by small interfering RNAs. Kurosawa T, Igarashi S, Nishizawa M, Onodera O. Biochem Biophys Res Commun; 2005 Nov 25; 337(3):1012-8. PubMed ID: 16225852 [Abstract] [Full Text] [Related]
29. Clinical and therapeutic implications of presymptomatic gene testing for familial amyloidotic polyneuropathy (FAP). Sales-Luís Mde L, Conceição I, de Carvalho M. Amyloid; 2003 Aug 25; 10 Suppl 1():26-31. PubMed ID: 14640039 [Abstract] [Full Text] [Related]
30. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met. Dardiotis E, Koutsou P, Zamba-Papanicolaou E, Vonta I, Hadjivassiliou M, Hadjigeorgiou G, Cariolou M, Christodoulou K, Kyriakides T. J Neurol Sci; 2009 Sep 15; 284(1-2):158-62. PubMed ID: 19493541 [Abstract] [Full Text] [Related]
31. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Planté-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G. Neurology; 2007 Aug 14; 69(7):693-8. PubMed ID: 17698792 [Abstract] [Full Text] [Related]
32. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y. Transplantation; 2004 Feb 15; 77(3):345-9. PubMed ID: 14966406 [Abstract] [Full Text] [Related]
33. Phenotypic heterogeneity in a family with FAP due to a TTR Leu58Arg mutation: a clinicopathologic study. Motozaki Y, Sugiyama Y, Ishida C, Komai K, Matsubara S, Yamada M. J Neurol Sci; 2007 Sep 15; 260(1-2):236-9. PubMed ID: 17466336 [Abstract] [Full Text] [Related]
34. [Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina]. Chaves M, Bettini M, Marciano S, Sáez S, Cristiano E, Rugiero M. Medicina (B Aires); 2016 Sep 15; 76(2):105-8. PubMed ID: 27135849 [Abstract] [Full Text] [Related]
35. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Suhr OB. Amyloid; 2003 Aug 15; 10 Suppl 1():77-83. PubMed ID: 14640045 [Abstract] [Full Text] [Related]
36. Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant). Okamoto S, Hörnsten R, Obayashi K, Wijayatunga P, Suhr OB. Liver Transpl; 2011 Feb 15; 17(2):122-8. PubMed ID: 21280184 [Abstract] [Full Text] [Related]
37. The molecular biology and clinical features of amyloid neuropathy. Benson MD, Kincaid JC. Muscle Nerve; 2007 Oct 15; 36(4):411-23. PubMed ID: 17554795 [Abstract] [Full Text] [Related]
38. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden. Soares ML, Coelho T, Sousa A, Holmgren G, Saraiva MJ, Kastner DL, Buxbaum JN. Eur J Hum Genet; 2004 Mar 15; 12(3):225-37. PubMed ID: 14673473 [Abstract] [Full Text] [Related]
39. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy. Tojo K, Sekijima Y, Machida K, Tsuchiya A, Yazaki M, Ikeda S. Muscle Nerve; 2008 Jun 15; 37(6):796-803. PubMed ID: 18506713 [Abstract] [Full Text] [Related]
40. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, Sobue G. Amyloid; 2011 Jun 15; 18(2):53-62. PubMed ID: 21463231 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]